The latest Weil European Distress Index reports that underlying vulnerabilities remain, with private investment still cautious across the entire European healthcare industry.
Despite being the third-most distressed sector in the final quarter last year, healthcare is expected to see distress continue to ease this year.
That said, underlying vulnerabilities remain, with private investment still cautious across the industry, pointing to latent fragilities beneath an otherwise improving headline picture, according to the latest edition of the Weil European Distress Index (WEDI)
“Weaker investment metrics in the healthcare sector reflect a cautious stance, shaped by high operating costs, tighter public funding, and a slowdown in private capital inflows,” the report says.
“Many firms remain focused on margin preservation rather than expansion,” it continues.
This comes against a background of uncertainty.
The broader outlook for corporate distress this year remains uncertain and nuanced. While the global economy has managed to avoid a sharp downturn, persistent structural weaknesses, a complex geopolitical landscape and tighter financial conditions continue to weigh on sentiment and corporate fundamentals, it writes.
“A modest easing in the aggregate index at the end of 2025 should not be mistaken for a broad-based recovery. Distress remains persistent and increasingly uneven, driven by pressure on liquidity and investment,” said Neil Devaney, partner and co-head of Weil’s London restructuring practice.
Further pressure
In the UK, recent Budget measures – including higher National Insurance and minimum wage costs – are set to add further pressure in 2026. With growth expected to offer little relief over the coming years, these pressures are unlikely to ease quickly.”
Ranking third this quarter, the UK has seen elevated pressure across liquidity, profitability and risk metrics, amid subdued business confidence and cautious investment. While the Spring Budget was less damaging to consumer demand than initially feared, it has done little to lift sentiment.
“The outlook for Europe’s largest economies in 2026 is defined less by a single trajectory and more by pervasive uncertainty,” said Andrew Wilkinson, partner and co-head of Weil’s London restructuring practice.
“In particular, the challenges around structural shifts – from the adoption of GenAI, rapid increase in defence spending, debt burdens at a sovereign level, US-EU relations and climate transition – alongside general geopolitical and policy uncertainty, are weighing heavily on investment decisions,” he added.
Certainly, the shift to adoption and investment in AI is notable. A report last week from US fintech firm Tipalti pointed out that global healthcare investment in AI had jumped 2,258% since 2012 to $11.6 billion (£8.6 billion) last year.
